Suzetrigine for Pain Relief
What You Need to Know Before You Apply
What is the purpose of this trial?
Local anesthetic infiltration is a primary source of acute pain during stereotactic procedures.
Who Is on the Research Team?
Stephen B Tatter, MD
Principal Investigator
Wake Forest University Health Sciences
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants self-administer either Suzetrigine or Acetaminophen at home prior to the procedure to assess pain reduction during local anesthetic infiltration and head frame application
Follow-up
Participants are monitored for pain and anxiety levels using VAS scores immediately after the procedure and reassessed at Hour 24
What Are the Treatments Tested in This Trial?
Interventions
- Suzetrigine
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Suzetrigine (100mg) - is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.
acetaminophen (1000 mg) - is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.